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Phages are recognized as the most abundant and diverse entities on the planet. Their diversity is determined predominantly by
their dynamic adaptation capacities when confronted with different selective pressures in an endless cycle of coevolution with a
widespread group of bacterial hosts. At the end of the infection cycle, progeny virions are confronted with a rigid cell wall that
hinders their release into the environment and the opportunity to start a new infection cycle. Consequently, phages encode hy-
drolytic enzymes, called endolysins, to digest the peptidoglycan. In this work, we bring to light all phage endolysins found in
completely sequenced double-stranded nucleic acid phage genomes and uncover clues that explain the phage-endolysin-host
ecology that led phages to recruit unique and specialized endolysins.
Bacteriophages (phages) are the most abundant living entitieson Earth and can be found in every conceivable habitat.
Phages outnumber bacteria by an estimated 10-fold, accounting
for a total population size of 1031 phage particles able to infect 108
species (1–4). As natural predators of bacteria, these viruses can
kill 50% of the bacteria produced every day, information which
demonstrates their ecological importance and impact on bacterial
evolution (4, 5).
Phages are tremendously diversified, with genome sizes from
as low as 17 kbp up to 0.5 Mbp, and constitute a reservoir of great
genetic diversity, which is supported by the high frequency of
novel genes found in newly characterized phage genomes. The
percentage of genes carried in a newly sequenced genome that
present homology to genes deposited in existing databases is usu-
ally low, in the range of 20% to 40% (5, 6). This high diversifica-
tion in the phage population can be attributed to the high number
of different bacterial hosts available for phage infection and the
ability of phages to rapidly evolve in order to circumvent bacterial
resistance mechanisms (7, 8). Even so, phages able to infect a
common host may exhibit great diversity, with little or no identi-
fiable nucleotide sequence similarity between them (9). The phage
genomes are typically mosaic, with individual genes, or groups of
genes, shared among unrelated genomes as a result of horizontal
and vertical gene transfer during phage evolution, particularly as a
result of recombination events between temperate phages
(10–13).
The morphology of the phage particles and the type of nu-
cleic acid form the basis of their classification, a responsibility
attributed to the International Committee on the Taxonomy of
Viruses (ICTV). However, ICTV’s classification method is now
being rectified to integrate genomic and proteomic homology
(14). The major order of phages is the Caudovirales, with 96%
of all reported phages (15). Caudovirales virions possess dou-
ble-stranded DNA (dsDNA) genomes enclosed in heads with
icosahedral symmetry and with tails that vary in length. These
tailed phages are subdivided into three families: Siphoviridae
(representing 61%), with long, flexible, and noncontractile
tails, Myoviridae (representing 25%), having long, rigid, and
contractile tails, and Podoviridae (representing 14%), with
short and noncontractile tails. The remaining nontailed phages
belong to a small and highly variable group, with single-
stranded DNA (ssDNA), ssRNA, or dsRNA (3).
Phage replication demands a strategy for progeny release and
dispersion to enable infection of new hosts. With the exception of
the few known filamentous phages, which continuously extrude
their progeny across the cell wall without killing their host cells, all
phages lyse their bacterial hosts by compromising the structural
integrity of the peptidoglycan (PG) layer (16–18). PG (or murein),
a heteropolymer consisting of glycan strands cross-linked by pep-
tides, forms an exoskeleton that withstands the internal cytoplas-
mic osmotic pressure, providing structural integrity to the cell
(19–21). Consequently, compromising the PG will lead to an un-
sustainable internal osmotic pressure, ultimately resulting in the
burst of the cell and progeny release. All double-stranded nucleic
acid (dsNA) genome phages degrade the PG through an essential
genome-encoded enzyme—the endolysin (17, 18). The muralytic
activity of endolysins allows their classification according to the
bond of the PG on which the enzymes act. At least four types of
endolysins have already been identified: (i) lysozymes and (ii)
transglycosidases act on the glycosidic bond that links the amino
sugars in the cell wall, and (iii) amidases and (iv) endopeptidases
act on the amide and peptide bonds of the cross-linking oligopep-
tide stems and interpeptide bridges (Fig. 1) (22–24).
An important issue is the regulation of the endolysin-mediated
lysis event that has evolved individually to optimize phage fitness.
The holin-endolysin system (lacking secretory signals), known as
the lambda paradigm, is thought to be universal in almost all
dsDNA phages, with some exceptions (23). In this system, endo-
lysins accumulate in the intracellular space due to the bacterial
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inner membrane. Subsequently, a small hydrophobic membrane-
spanning protein called holin is expressed at a genetically prede-
termined time and accumulates in clusters producing homo-oli-
gomeric pores in the inner membrane, thereby exposing the PG
layer to the endolysin (17, 25, 26). Some endolysins, such as the
Bacillus cereus phage TP21-L, Oenococcus oeni phage fOg44, and
Lactobacillus plantarum phage Øg1e endolysins, present different
intrinsic signal sequences that allow them to pass the cytoplasmic
membrane and reach the PG in a holin-independent manner (27,
28). The referred lytic systems are reported exclusively for Caudo-
virales phages, and not much is known about lytic systems present
in cassettes of phages outside this order. A rare and interesting case
is the Tectiviridae phage PRD1, in which the endolysin is associ-
ated with the viral membrane (29). The capacity of endolysins
from a Gram-positive (G) background to lyse bacteria when
added externally was already tested in vitro, leading to the com-
plete death of a streptococcus culture in a few seconds (30). The
unique ability of endolysins to rapidly kill bacteria in a species-
specific manner renders them promising as antibacterial and bio-
control agents and rapidly caught attention of many researchers
that envisage applications in fermentations, food preservation,
biotechnology, and medicine (23, 31). Exogenous action of endo-
lysins on Gram-negative (G) bacteria is still restricted due to the
presence of an impermeable outer membrane, thus representing
one of the most important challenges in endolysin therapy.
Although in recent years, endolysins have proven to be an in-
teresting alternative to antibiotics, their sequences are poorly clas-
sified. PG hydrolases constitute an enormous pool of protein se-
quences that contain a broad range of lytic domains involved in
PG digestion. To date, phage endolysins have been annotated
mostly according to their enzymatic catalytic family; however,
only a few researchers have tried to analyze their specific classes.
Here we describe a bioinformatic analysis of all endolysins found
in completely sequenced dsNA phage genomes, unraveling all the
selected evolutionary markers behind the phage-endolysin-host
ecology association.
MATERIALS AND METHODS
Computer analysis. All computer analyses were performed on Intel-
based PCs with the Windows 7 operating system with a Virtual Machine
(Oracle VM Virtual Box) running the Ubuntu 12.05 operating system for
sequence alignment using Clustal Omega (version 1.1.0) (32).
Sequence database. To perform the study of the endolysin evolution/
comparison, a sequence database was created by gathering phages as-
signed as completely sequenced at the NCBI (http://www.ncbi.nlm.nih
.gov/pubmed). For the 890 retrieved phages, a query of the genome was
performed to encounter any identified endolysin during the sequencing
project. Putative endolysins were submitted to a BLASTP analysis (33) to
identify new undiscovered proteins. The BLASTP was executed using all
standard parameters with an E value cutoff of 1 105.
Endolysin motif search. We considered correct endolysin identifica-
tion (characterization of its type, catalytic characterization, and binding
domains) of the upmost importance, and therefore, a set of online search
platforms was used to accurately determine the protein cleavage and re-
action mechanism. All proteins from the database (723 putative endoly-
sins found in the 890 phages) were screened by the HHpred webserver
(http://toolkit.tuebingen.mpg.de/hhpred) using Pfam, InterProScan, and
COG with an E value cutoff of 1 105 and at least 80% query coverage.
The multiple-sequence-alignment (MSA) generation method used was
HHblits (34). Signal peptides were identified using SignalP (35) and Pre-
diSi (36). To conclude the analysis, the signal-arrest-release (SAR) motif
was queried. For that, we searched for transmembrane domains located at
the N terminus using SOSUI (37), TMHMM (38), Phobius (39), Octopus
(40), and Topcons (41). Endolysins for which a transmembrane domain
was identified by at least one of the mentioned softwares and which pres-
ent a high content (40% to 60%) of Gly/Ala and 0 to 2 basic residues (most
of which are Lys) (42) were thus annotated as presenting a SAR domain.
Protein cladogram. To understand the relation between our selected
proteins and to comprehend phage evolution, a phylogenetic study was
FIG 1 Schematic representation of how phage endolysins gain access to the PG through the most common holin-endolysin lytic system. A generalized PG
structure illustrates all cleavage sites found: 1, N-acetyl--D-muramidase (LYSO, MURA, SLT, TRANG, GH19, GH25, and GH108); 2, N-acetyl--D-gluco-
saminidase (GH19 and GLUCO); 3, N-acetylmuramoyl-L-alanine amidase (AMI-2, AMI-3, AMI02-C, and CHAP); 4, L-alanoyl-D-glutamate (LD) endopepti-
dase (VANY); 5, c-D-glutamyl-m-diaminopimelic acid (DL) peptidase (NLPC-P60 and PET-C39-2); 6, D-Ala-m-DAP (DD) endopeptidase (PET-M23 and
PET-M15-4); 7, m-DAP-m-DAP (LD) endopeptidase (PET-M23 and PET-M15-4); 8, D-alanyl-glycyl endopeptidase (CHAP); 9, D-alanyl-D-alanine peptidase
(CHAP); 10, m-diaminopimelic acid-D-alanine (PET-U40). PET-M15-3, YKUD, and NLPD are peptidases with an unknown cleavage site.
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performed using our protein database. For that, a cladogram was con-
structed using putative endolysin sequences of only completely sequenced
dsNA phage genomes. All these protein sequences were retrieved from our
database in FASTA format, aligned using Clustal Omega (beta version for
proteins only, v1.1.0) with the -o output.aln -MAC-RAM 30000 –v –v
parameters. The conversion to the PHYLIP format was done using Clust-
alX multiple alignment software (version 2.0). The phylogenetic con-
struction was obtained using the Phylogeny Inference Package (PHYLIP
v3.68) (43). The phylogenic analysis was performed using the following
algorithms: maximum likelihood (ML), neighbor joining (NJ), and par-
simony (P). These methods were applied to the PHYLIP sequence base
using PROML, PROTDISTNEIGHBOR, and PROTPARS, with
SEQBOOT programmed to 100 replicates to bootstrap and number seed
variation (the trees were compared to address similarity). Bootstrap val-
ues were calculated using CONSENSE. In all methods, the jumble number
used was 10 and the bootstrap values were all above 80%. Although more
than one method was used to construct the trees, the ML method was
selected since it chooses those trees that maximize the probability of ob-
serving the data. Phylogenetic trees obtained from PHYLIP were repre-
sented and arranged, without being altered, using the FigTree software
(v1.3.1) (44).
RESULTS AND DISCUSSION
Outline. To study phage-host-endolysin ecology, a comprehen-
sive list of all endolysins from dsNA phages with completed ge-
nome sequences deposited in the NCBI database was compiled.
To sort a given open reading frame (ORF) as a probable endolysin,
two criteria were followed: (i) the presence of a putative catalytic
domain and (ii) the absence of additional domains with extrane-
ous function. The latter allowed distinguishing of endolysins from
structural lysins, also known as exolysins. For each encoded endo-
lysin, the following information was gathered: (i) the presence and
position of the enzymatic catalytic domain (ECD)/cell binding
domain (CBD), (ii) the phage family type, (iii) the corresponding
host Gram reaction, (iv) the host genus, and (v) the presence of
signal peptides/transmembrane domains. The data set, altogether,
includes a total of 890 complete phage sequences from which 723
putative endolysins were identified. Endolysins were identified in
136 Myoviridae, 378 Siphoviridae, 97 Podoviridae, nine Tectiviri-
dae (dsDNA), four Cystoviridae (dsRNA), and 99 unclassified
phages (see Table S1 in the supplemental material). Despite their
conserved biological function, phage endolysins are enzymatically
and architecturally tremendously diverse and hugely vary in
length and size. With a remarkable 24 different ECDs and 13 CBD
types (Table 1), these specialized enzymes comprehend 89 differ-
ent types of architectural organizations (Fig. 2) and belong to
phages infecting 64 different bacterial genera (Fig. 3), range from
72 to 578 amino acid residues with unique peptides/transmem-
brane signals (Fig. 4), and are evolutionarily distant from each
other (Fig. 5).
Endolysin-based lysis diversity among dsNA phages. The
complexity and variety of more than 100 different reported eubac-
terial PG chemotypes have driven an evolutionary pressure in
phages to refine their lytic cassette in order to compromise the
host cell wall (44). Toward this end, bacteriophages have acquired
a huge diversity of PG hydrolases (PGHs), varying in type, num-
ber, and organization of their catalytic and binding domains, all
illustrated in Fig. 2.
Endolysin ECDs. Phage glycosidase PGHs (EC 3.2.1.X) are a
group of enzymes belonging to the lysozyme-like superfamily that
catalyze the glycolytic cleavage of the O-glycosidic bond of the
bacterial PG. Glycosidase hydrolases (GHs), including GH24,
GH25, and GH108 (EC 3.2.1.17), are a structurally diverse set of
phage endolysin members with the same lysozyme activity cleav-
ing the MurNAc-N-GlcNAc bond of the carbohydrate backbone.
GH24 is the most predominant PGH, generally containing glob-
ular muramidase (MURA) or phage_lysozyme (LYSO) domains,
strictly present in lytic cassettes of phages infecting G bacteria. A
few exceptions are the modular endolysins derived from Synechoc-
occus phages S-CAM8, S-CBS3 (LYSO/PET15-3), and S-CBS1
(LYSO/PET39-2). GH25 endolysins, on the other hand, are ac-
quired by Siphoviridae viruses targeting G organisms, mostly
belonging to the Firmicutes family (e.g., Bacillus spp., Staphylococ-
cus spp., Streptococcus spp.), that can be linked to several distinct
C-terminal CBDs (SLAP, CPL-7, LYSM, SH3, and FOG). The
GH108 class contains just nine endolysins with an enzymatic ac-
tivity restricted to phages infecting only seven G genera and has
never been characterized in vitro. Other soluble lytic transglyco-
sylase (SLT) and transglycosylase (TRANG) domains belong to
the lytic transglycosylase group of enzymes. Although degrading
the same PG covalent bond as the previous group, they are not
hydrolases. SLT-encoding endolysins are globular and acquired
by phages to target GPG (found inBurkholderia,Campylobacter,
Escherichia, and Pseudomonas phage endolysins), while the
TRANG-type enzymes are modular and specialized in G PG
(found only in the mycobacteriophages Gladiator, Da Vinci,
Hammer, Trixie, Jeffabunny, Blue7, and Turbido). Pseudomonas
aeruginosa phage phiKZ endolysin is an example of a (SLT) lytic
transglycosylase for which activity has been biochemically con-
firmed (45). GH19 (EC 3.2.1.14) is a distinct class cleaving the
glycosidic -1,4 linkages of unbranched chains of N-acetylglucos-
amine polymers. This structure is uncommon in bacterial cell
walls; therefore, one can speculate that GH19-identified endoly-
sins can have glycosidase activity, acting either as N-acetylglucos-
aminidase or as N-acetylmuramidase. They are found mainly in
Mycobacterium spp.-, Gordonia spp.-, and Corynebacterium spp.-
infecting phages and have been recently characterized in Pseu-
domonas fluorescens OBP and Salmonella enterica serovar Enterit-
idis phage PVP-SE1 (46, 47). Finally, glucosaminidases (GLUCO)
(EC.3.2.1.52) are core-specific lysosomal enzymes cleaving the
GlcNAc-(-1,4)-MurNAc bond. In phage endolysins, this do-
main is repeatedly found in Siphoviridae phage lytic cassettes that
mostly target hosts within the Firmicutes family. Although this
catalytic class is frequently present in Staphylococcus-infecting
phages containing three domains in a cysteine-, histidine-depen-
dent amidohydrolase/peptidase (CHAP)/amidase_2 (AMI-2)/
GLUCO module, only the Streptococcus agalactiae prophage
LambdaSa2 was shown to display -D-N-acetylglucosaminidase
activity (48).
Phage amidase PGHs (EC 3.5.1.28) and N-acetylmuramoyl-L-
alanine amidases are endolysins composed of domains of the
AMI-2, AMI-3, AMI-5, and AMI02-C types, cleaving the same PG
bond between the N-acetylmuramoyl residues and L-amino acid
residues. AMI-2, the most predominant domain (representing
28.22%) found in Mycobacterium-like and Staphylococcus-like en-
dolysins, is usually located as a central domain. Escherichia phage
T7 and Staphylococcus phage Twort endolysins are well-studied
cases (49, 50). AMI-3 domains are predominant on G-like en-
dolysins. It is important to highlight that all Staphylococcus phage
endolysins bearing AMI-3 have a CHAP/AMI-3/SH3-5 structure.
Finally, AMI02-C is located at the C-terminal side and is merely
present in some Bacillus and Clostridium-like endolysins. To our
Oliveira et al.
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knowledge, no in vitro studies have yet been performed to confirm
lytic activity of this domain.
Phage carboxy/endopeptidase PGHs form the larger group of
ECDs that cleave short peptides that link the sugar polymers of the
PG. A total of nine different peptidases (PET), PET-M23, NLPC-
P60, NLPD, PET-U40, and PET-C39-2 endopeptidases and
VANY, PET-M15-4, PET-M15-3, and YKUD domain carboxy-
peptidases, were found. PET-M23 is found in phage endolysins
from several genera. It has been reported that the Bacillus subtilis
prophage Sp- endolysin (named CwlP) contains a related do-
main, and it has been shown to function as a DD-endopeptidase
cleaving 4R3 D-Ala-meso-diaminopimelic acid (m-DAP) inter-
peptide linkages (51). The NLPC-P60 domain is described as a
superfamily with a very different range of activities. Only found in
G-like endolysins, they can cleave N-acetylmuramate-L-alanine
linkages, as was shown for the Streptococcus phage Dp-1 and Lac-
tococcus lactis phage BK5-T endolysins (52, 53). More recently,
NLPC-P60, found in some mycobacteriophage endolysins, was
described as a cysteine proteinase cleaving the 4¡3 linkage be-
tween D-Glu and m-DAP residues (54). PET-C39-2 was first iden-
tified in lysin A proteins (mycobacteriophage cell wall hydrolytic
enzymes), cleaving the D-Glu–m-DAP linkages (54). This pepti-
dase is also a cysteine proteinase and is present mainly in myco-
bacteriophages. VANY is described in the Pfam database as a D-al-
anyl-D-alanine carboxypeptidase, possibly due to the Enterococcus
faecium vancomycin resistance protein VanY (55). Concerning its
phage origin, this domain was identified in both G- and G-like
endolysins, particularly in phages infecting Listeria, Bacillus, and
TABLE 1 Identified putative endolysin catalytic and binding domainsa
Predicted catalytic or binding
domain
Conserved
domain(s) Phage example
HHpred probability (%)/
E value
Predicted catalytic domains
Phage_lysozyme (LYSO) PF00959/IPR002196 Burkholderia phage Bcep176 100.0/3.1E34
Muramidase (MURA) COG4678 Enterobacteria phage lambda 100.0/6.2E52
Glyco_hydro_19 (GH19) PF00182/IPR000726 Pseudomonas phage F10 100.0/6.8E42
Glyco_hydro_25 (GH25) PF01183/IPR002053 Clostridium phage phiCTP1 100.0/4.9E48
Glyco_hydro_108 (GH108) PF05838/IPR008565 Vibrio phage VP882 100.0/1.5E37
SLT PF01464/IPR008258 Pseudomonas phage B3 99.9/2.9E23
Transglycosylase (TRANG) PF06737/IPR010618 Mycobacterium phage Blue7 100.0/8.3E31
Glucosaminidase (GLUCO) PF01832/IPR002901 Bacillus phage Bam35c 100.0/6.8E32
Amidase02_C (AMI02-C) PF12123/IPR021976 Clostridium phage phiCD38-2 98.2/1.2E06
Amidase_5 (AMI-5) PF05382/IPR008044 Streptococcus phage 858 99.9/3.0E26
Amidase_3 (AMI-3) PF01520/IPR002508 Listeria phage 2389 100.0/6.4E44
Amidase_2 (AMI-2) PF01510/IPR002502 Gordonia phage GTE7 100.0/2.4E29
NlpD (NLPD) COG0739 Mycobacterium phage Timshel 97.8/2E05
VanY (VANY) PF02557/IPR003709 Yersinia phage PY100 99.9/1.2E24
Peptidase_U40 (PET-U40) PF10464/IPR19505 Pseudomonas phage phi-6 100.0/2E138
Peptidase_M15_3 (PET-15-3) PF08291/IPR013230 Bacteroides phage B40-8 100.0/1.1E38
Peptidase_M15_4 (PET-15-4) PF13539 Salmonella phage ST64T 99.7/8.2E17
Peptidase_M23 (PET-M23) PF01551/IPR016047 Thermus phage P23-45 100.0/2E28
YkuD (YKUD) PF03734/IPR005490 Synechococcus phage S-CBS4 99.7/7.1E18
NLPC_P60 (NLPC-P60) PF00877/IPR000064 Mycobacterium phage Dori 99.8/2.9E19
Peptidase_C39_2 (PET-C39-2) PF13529 Rhodococcus phage REQ3 99.8/1.8E17
CHAP PF05257/IPR007921 Staphylococcus phage phi13 99.8/9.4E22
DUF3597 (DUF) PF12200/IPR022016 Listeria phage A188 99.5/7.6E15
Predicted binding domains
PG_binding_3 (PG-3) PF09374/IPR018537 Vibrio phage VP882 99.9/7.9E25
LysM (LYSM) PF01476/IPR018392 Enterococcus phage phiEf11 99.0/1.4E10
LysM (LYSM) smart00257 Lactobacillus phage Lb338-1 99.5/5.0E14
SH3_3 (SH3-3) PF08239/IPR013247 Lactobacillus phage Lv-1 97.6/5.3E05
SH3_5 (SH3-5) PF08460/IPR013667 Staphylococcus phage phi2958PVL 99.5/1.5E14
PG_binding_1 (PG-1) PF01471/IPR002477 Mycobacterium phage Hertubise 99.5/8.7E14
ChW (CHW) smart00728 Lactobacillus phage A2 99.3/2.3E12
ChW (CHW) PF07538/IPR006637 Lactococcus phage 949 99.2/7.1E12
Cpl-7 (CPL7) PF08230/IPR013168 Streptococcus phage SMP 99.5/2.4E14
LGFP PF08310/IPR013207 Nocardia phage NBR1 99.7/1.6E17
SH3-related (SH3-r) SUPFAM0051050 Listeria phage A500 100.0/4.4E54
FOG COG5263 Listeria phage B054 99.8/4.0E19
SH3b smart00287 Lactococcus phage P087 97.5/4.4E05
SPOR PF05036/IPR007730 Bacillus phage AP50 99.1/1.8E10
SLAP PF03217/IPR004903 Bacillus phage 0305phi8-36 98.9 /3.0E08
a The acronyms used in all catalytic and binding domains are given in parentheses. Domain acronyms: Glyco_hydro, glycoside hydrolase; SLT, soluble lytic transglycosylase; CHAP,
cysteine-, histidine-dependent amidohydrolases/peptidases; DUF, domain of unknown function; LYSM, lysin motif; CHW, clostridial hydrophobic with conserved W (Trp); SPOR,
sporulation-related domain; SLAP, bacterial surface layer protein. Databases: PF, Pfam; COG, clusters of orthologous groups of proteins; IPR, InterProScan; Smart, Simple
Modular Architecture Research Tool. AMI-5 is further considered NLPC-P60 (E values differ at most by 5 log).
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Escherichia organisms. In opposition to what is described by Pfam,
the Listeria phage endolysins Ply118 and Ply500 and the entero-
bacteriophage T5 endolysin classified as VANY carboxypeptidases
act as L-alanyl-D-glutamate endopeptidases (56, 57). PET-M15-4
is a domain also described as D-alanyl-D-alanine carboxypepti-
dase; however, it has been predicted to display L-Ala-D-Glu activ-
ity (54). This domain was found in several mycobacteriophages
and in some phages infecting G organisms, such as Salmonella.
PET-M15-3 peptidase domains are metallopeptidase domains be-
longing to the family M15A, found in only nine different endoly-
sins, mainly from G-infecting phages. The exact cleavage site has
not yet been identified due to the lack of biochemical evidence.
CHAP is a common domain found in phage endolysins identified
in 87 proteins. This CHAP domain is strictly encoded in phages
infecting G hosts, predominantly in phages infecting Streptococ-
cus spp. and Staphylococcus spp. Of particular interest is their as-
sociation with several other families of amidases, a connection
which suggests that they might act in a cooperative manner to
cleave multiple PG substrates. Reports have shown that CHAP can
serve as a peptidase or amidase, acting as a D-alanyl-L-alanyl en-
dopeptidase (in Streptococcus phage B30), as a D-alanyl-glycyl en-
dopeptidase (in Staphylococcus phage phi11), or as an N-acetyl-
muramoyl-L-analine amidase (in Streptococcus phage C1). The
latter endolysin (PlyC) is a unique multimeric protein composed of
two separate gene products (PlyA and PlyB) (58–60). The remaining
NLPD, PET-U40, and YKUD have been found in only one phage
FIG 2 Diversity of ECDs/CBDs found at the N and C termini of the four major endolysin classes centrally located (from all 723 putative endolysins):
N-acetylmuramidases (blue scale), N-acetylglucosaminidases (purple), N-acetylmuramoyl-L-alanine, and carboxy/endopeptidases (green scale). CHAP (or-
ange) can act as an amidase or peptidase. These four major classes have been centrally located to show all ECDs (with colors mentioned above) and CBDs (gray
scale) found attached to their N and C termini. For the correct interpretation of the schematic representation, for all endolysins found with a CHAP domain, a
GLUCO at their N terminus was observed. In some proteins, a GLUCO, AMI-2, and AMI-3 domain at the C terminus was identified.
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FIG 3 Nature and repartition of PGH domains derived from 727 endolysins.
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endolysin each, mycobacteriophage Timshel (PET-M15-4/NLPD),
Cystoviridae Pseudomonas phage phi-6 (PET-U40), and Synechococ-
cus phage S-CBS4 (GLUCO/YKUD) endolysins, respectively. NLPD
and YKUD remain experimentally uncharacterized.
Phage endolysins with multicatalytic activities. Through
evolution, endolysins appear to have acquired certain substrate
specificities by obtaining multiple ECDs found in bacteriophages
infecting a range of 11 different genera but present predominantly
in Staphylococcus and Mycobacterium-like phages. The latter have
26 different types of structures, 14 of which combine two ECDs.
The most prevalent ones contain an N-terminal predicted pepti-
dase, centrally located AMI-2, MURA, and TRANG, and a C-ter-
minal PG-1. Less frequently, staphylococcus-like endolysins with
multiple ECDs can contain up to three ECDs with alternating
CHAP/AMI-3/SH3-5, CHAP/AMI-2/SH3-5, or CHAP/AMI-2/
GLUCO modules. An unusual double amidase activity was found
with an AMI-2/AMI-2C structure and an AMI-3/AMI-2C struc-
ture in six Bacillus phages and two Clostridium phages, respec-
tively. In G-like endolysins, the few multi-ECDs found belong to
the Prochlorococcus marinus phage PSS2 and 4 Synechococcus
phages with an N-terminal GH activity (MURA or GLUCO) and
an additional peptidase activity (PET-C39-2, YKUD, or PET-
M15-3). Another notable detail is that 150 (77%) of the 196 an-
notated multi-ECD phage endolysins belong to Siphoviridae vi-
ruses, mostly infecting G hosts. Studied examples including
plural active lytic domains are the staphylococcal 11 (59), the
group B streptococcal endolysin B30 (61), and the streptococcal
lSa2 phage endolysin (48).
ECDs— evolutionary claims. The structural distribution of
the endolysin domains, as illustrated in Fig. 3, reflects the phages’
different strategies to ensure the same biological function, i.e., to
disrupt the PG. The acquirement of specific ECDs (Table 1) from
a large pool of potential candidates may be influenced by three
factors.
(i) The specific ECD substrate may be restricted to a few bac-
teria. For instance, because Staphylococcus, Streptococcus, and Lac-
tococcus have unique 3¡4 glycine pentaglycine (Gly)5, dialanine
(L-Ala-L-Ala), or L-Lys-D-Asp interpeptide bridges within the PG,
their specific phages have acquired a CHAP domain that exclu-
sively cleaves these links (62). LYSO activity is dominant in phages
infecting G species. This can be explained by the ability of many
G pathogens to modify their glycan strands by N-glycosylation,
de-N-acetylations, and/or O-acetylations that contribute to high
levels of resistance to lysozyme (62).
(ii) The composition and length of the PG structure vary with
growth phase and conditions. As a result of generation of the
FIG 4 Phage endolysins predicted to be secreted via the signal-arrest-release system (SAR). Only the first 50 residues are shown. Transmembrane domains are
highlighted in light gray, and the predicted catalytic residue of the endolysin is highlighted in dark gray.
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cellular shape, its maintenance, and bacterial adaptation, bacterial
PG dynamics continuously incorporate new material into the sac-
culus with different muropeptide compositions (63), meaning
biosynthesis of new (and removal of old) substrates available for
endolysin targeting. This would drive phages to a careful selection
of a capable endolysin that efficiently digests all PG variants. Esch-
erichia coli, Mycobacteria, and Streptococcus pneumoniae are
known microorganisms in which muropeptides undergo several
changes (63–65). Interestingly, their infecting phages represent
the niche with lytic cassettes that span the greatest ECD diversity
and multiplicity. Mycobacteriophage endolysins especially have
an impressive 127 multifunctional ECD combinations, with
preferred combinations of PEP-M13/AMI-2/PG-1, NLPC-P60/
GH25, and PET-M15-4/GH19 modules. In some cases, ECDs
within the same endolysin may act synergistically, cooperatively,
or even alone.
(iii) Distinct ECDs guarantee a similar biological function.
Cleavage of a specific bacterial PG is not restricted to a single ECD
but can be ensured by several ECDs with different cleavage sites.
For instance, the MurNAc-N-GlcNAc glycosidase activity is per-
formed exclusively by the LYSO-containing endolysins in the
Xanthomonas phages, whereas at least four distinct domains
(LYSO, MURA, GH108, and SLT) are responsible for this activity
in Escherichia phage endolysins. The amidase cleavage of the D-
lactyl moieties of MurNAc and L-alanine of the short stem peptide
(NAM-amidase) is carried out by AMI-2 in Vibrio phage endoly-
sins, while in Bacillus-like endolysins, it is performed by distinct
AMI02-C, AMI-2, and AMI-3 domains. In general, ECDs are not
global but, rather, are found in a restrictive number of bacterial gen-
era. ECD variety among endolysins resulted from the historical battle
between phage and bacterium, attaining a wealth of possible PGH
sequences to reach the same final outcome: bacteriolysis.
Endolysin CBDs. Endolysin modularity can also associate
ECDs with a selected cell binding domain (CBD) (Table 1) to
target different receptors (e.g., PG subunits, saccharides, proteins,
lipoteichoic acid, choline, and PG itself). Notably, all CBDs are
present mostly in Bacillus, Lactobacillus, Lactococcus, Mycobacte-
rium, Staphylococcus, and Streptococcus phage endolysins (Fig. 3).
Among the great variety of CBD motifs found, only PG-1, SH3,
LYSM, and CPL-7 have been characterized in vitro (46, 66, 67).
PG-1 is almost only restricted to phages infecting G genera, with
a few exceptions detected in G-like endolysins (Salmonella phage
PVP-SE1 and Pseudomonas phages phiKZ, EL, 201phi21, and
OBP), with a unique inverse rearrangement (one or more PG-1
CBDs at the N termini). PG-3 type has been acquired from phages
with a rare modular arrangement (GH108/PG-3), infecting G
counterparts. SH3 domains commonly found in autolysins and
phage endolysins often belong to the SH3b, SH3-3, or SH3-5 type.
This CBD, shared by lysostaphin (a bacteriocin from Staphylococ-
cus simulans bv. staphylolyticus) and its homologue, hydrolase
ALE-1, has been uncovered to recognize pentaglycine cross
bridges in PG (68, 69). Therefore, the fact that most of the SH3
domains are found in Staphylococcus-like endolysins is not sur-
prising. The LysM domain is considered to be the CBD with the
widest range of receptors, identified in more than 4,000 proteins
of both prokaryotes and eukaryotes. It has been postulated that
this domain binds to various types of PG and most likely recog-
nizes the N-acetylglucosamine moiety (70). This is in agreement
with our findings that show that LysM is always correlated to
MurNAc-N-GlcNAc glycosidase activity (LYSO or GH25), with
the exception of three endolysins, in which LysM is joined with an
amidase domain (AMI-2 or AMI-3 type). Interestingly, the LysM
domain is often found in double motifs, having a unique architec-
ture of three motifs in the Lactobacillus phage Lb338-1 endolysin
(GH25/LYSM/LYSM/LYSM). Endolysin modules containing the
less abundant CPL-7 are GH25/Cpl-7/Cpl-7, NLPC-P60/GH25/
Cpl-7, and NLPC-P60/Cpl-7/GLUCO, present in Clostridium
phage (phiCTP1), Mycobacterium phages (Optimus and Baka),
and Streptococcus phages (SMP and 315.3), respectively. Although
CBD location is usually found at the N or C terminus, the afore-
mentioned CBDs (LYSM, CPL-7, and PG-1) can also be located as
central domains (e.g., mycobacteriophage Adjutor with NLPC-
P60/PG-1/PG-1/GH19, Streptococcus phage SMP with NLPC/
CPL-7/CPL-7/GLUCO, and Streptococcus phage phi-SsUD.1 with
AMI-3/LYSM/LYSM/NLPC-P60). Concerning CHW (clostridial
hydrophobic with conserved W), it has been stated that this pro-
tein family is almost exclusively limited to the Clostridium aceto-
butylicumbacterial species (71). Our results reveal only nine CHW
domains detected in three Lactococcus and six Lactobacillus phage
endolysins. Curiously, this domain is always present in endolysins
attached to an AMI-2-type domain and bears multi-CHW motif
copies. The Lactococcus phage A2 endolysin has an AMI-2/CHW/
CHW/CHW arrangement, while Lactococcus phages 949, ascc-
phi28, and KSY1 contain the AMI-2/CHW/CHW modules. The
acquirement of other uncommon CBD motifs, like LGFP, SPOR,
FIG 5 Radial cladogram of bacteriophage endolysins of all characterized
phages. The cladogram was constructed using PHYLIP v3.68 with a neighbor-
joining algorithm. The resulting cladogram was represented and arranged,
without being altered, using the FigTree software (version 1.3.1). Highlighted
areas are numbered and correspond to the more-conserved clades. 1, Myco-
bacterium/Siphoviridae/AMI-2; 2, G/GH25; 3, Lactococcus/Siphoviridae/
AMI-2; 4, G/LYSO; 5, G/MURA; 6, Streptococcus/Siphoviridae/NLPC-P60;
7, G/Podoviridae/AMI-2; 8, G/Myoviridae/VANY; 9, Staphylococcus/Sipho-
viridae; 10, G/GH19; 11, Escherichia/Tectiviridae/SLT; 12, Mycobacterium/
Siphoviridae/NLPC-P60/GH25; 13, Mycobacterium/Siphoviridae/PET-M15-4/
PG1; 14, Mycobacterium/Siphoviridae/PETM-15-4/GH19; 15, Mycobacterium/
Siphoviridae/PET-M23/AMI-2; 16, Mycobacterium/Siphoviridae/PET-C39-2/
GH19.
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FOG, and SLAP, can represent alternative ways for tighter binding
by directing the catalytic cavity into target muropeptides or
changes in species specificity. Remarkably, FOG motifs are char-
acterized by having six CBD (PF01473) repeats found only in six
streptococcal phages (Cp-1, Dp-1, EJ-1, MM1, PH10, and SM1)
and one Listeria phage (B054). To our knowledge, these CBDs
have never been characterized in vitro in the big pool of phage
PGHs.
CBDs— evolutionary claims. An evolutionary relationship
between S. pneumoniae autolysins and some streptococcal phage
endolysins was originally proposed based on their significant nu-
cleotide sequence similarities (72). It was suggested that modular
endolysins may have evolved by the interchange of phage and
bacterial genes encoding individual modules (72), gaining strong
support after the creation of functional chimeric phage-bacterial
enzymes, which consisted of one phage- and one bacterial-derived
exolysin domain (73, 74). The recruitment and distribution of
CBD through phage genomes (Fig. 3) can be correlated by differ-
ent facts.
(i) Specific CBD receptors may be restricted to a few bacteria.
As the major role of endolysins is to enable progeny virions to be
released from the host cell to ensure the effective release of phages,
the CBDs may have evolved to target a unique and essential com-
ponent of the host cell wall (75). This would explain the variability
of this module and the highly selective lytic activity of endolysins.
Therefore, in some cases, CBDs can confer highly specific ligand
recognition to endolysins, resulting in a very narrow substrate
spectrum of the full-length endolysin, often limited to the host
species or strain (76) or, to a lesser extent, genus specific (67, 77).
Well-studied examples of ligand recognition are the pneumococ-
cal endolysins derived from phages Cp-1 (Cpl-1 endolysin), Dp-1
(PAL endolysin), and Ej-1 (Ej-1 endolysin). Their corresponding
CBDs specifically bind choline, which is present only in teichoic
acids of the pneumococcal cell wall and which is essential for bac-
terial viability (52, 72, 78). Also, the CBDs of the Listeria monocy-
togenes bacteriophage endolysins Ply118 and Ply500 can bind to
different Listeria serovar groups, as visualized by fusions with
green fluorescent protein (GFP), showing that they are correlated
with the occurrence of somatic antigens related to these serovars
(67).
(ii) Minimal disruption of normal flora. The reason for the
presence of a CBD typically seen in G-like endolysins relies on
the absence of an outer membrane in G bacteria. After external
bacterial lysis, CBD maintains the endolysin tethered to the PG,
making them unavailable for degrading any adjacent G PG from
forthcoming potential hosts (bacterial threshold), thereby not
compromising phage survival (79). The strong substrate specific-
ity of the L. monocytogenes phage endolysins Ply118 and Ply500 of
nanomolar affinities is in favor of this hypothesis, suggesting that
they have evolved to bind irreversibly to their cell wall ligand (67).
On the other hand, the presence of an outer membrane in G
bacteria that impairs direct contact of the endolysin from the out-
side eliminates the need for a CBD in endolysins from phages
infecting these bacteria. In our in silico analysis, we observed a
predominant CBD distribution among G-infecting phages (Fig.
3). Lactobacillus, Lactococcus, and Bacillus genera represent the
phage niche with the most diverse CBD collection (PG-1, SH3-3,
SH3-5, SH3b, CHW, LYSM, and SPOR). Excellent examples are
phage endolysins with 3 CBDs, observed only in Lactobacillus
phage A2 (AMI-2/CHW/CHW/CHW) and Lactobacillus phage
Lb338-1 (GH25/LYSM/LYSM/LYSM), or endolysins containing
different types of CBDs, as is the case for the Lactobacillus phage
phiAT3 endolysin (GH25/SH3-5/LYSM).
(iii) Catalytic activity regulator. Rather than binding to the
cell wall, CBD-associated domains sometimes can play determin-
ing roles in the enzymatic efficiency by allowing enough substrate
to reach the catalytic site. Other carbohydrate hydrolases, such as
xylanases and cellulases that cleave insoluble carbohydrate poly-
mers, share a similar modular architecture (80), and their CBDs
act by increasing enzyme-substrate proximity (81). Equilibrium
association constants of CBDs of Listeria phage endolysins Ply118
and Ply500 place them in the same range as affinity-matured an-
tibodies against bacterial cell surface antigens. Interestingly, the
deletion of their CBDs rendered enzymes with no muralytic activ-
ity (67). Also, the activity of a C-terminally truncated Clostridium
phage phi3626 endolysin was entirely abolished, emphasizing the
important role that CBDs play in the enzyme’s activity (82). As
opposed to previous observations, structural analysis of PlyL in-
dicates that the C-terminal CBD not only targets the endolysin to
a specific ligand but also inhibits the catalytic activity in the ab-
sence of the cognate substrate. It has been hypothesized that sub-
strate recognition by the CBD of PlyL disrupts interactions be-
tween the CBD and the ECD, relieving the inhibitory effect on the
latter (83). These interdomain interactions are absent in the C-ter-
minally truncated variant, converting the catalytic domain into a
constitutively active domain. Therefore, B. subtilis, which is lack-
ing the cognate target, is hydrolyzed more efficiently by the trun-
cated form than by the full-length version. Consequently, the role
of the CBD is variable, and therefore, each case must be examined
individually.
(iv) Is it possible to lose nonessential domains? Though a
multidomain architecture is indicative of a modular enzyme, it
does not guarantee its functionality as a modular protein. An anal-
ogy comparison can be done for phage endolysins, in which the
presence of a CBD does not often constitute a prerequisite for
enzyme activity. Deletion of the CBD of the L. monocytogenes en-
dolysin PlyPSA only reduces the lytic activity (84). Also, the C-ter-
minal domain of the Lactobacillus delbrueckii subsp. lactis bacte-
riophage LL-H endolysin can be removed without destroying the
lytic activity (85). C-terminal deletions of the Staphylococcus au-
reus bacteriophage endolysins PlyTW and Ply187, L. monocyto-
genes bacteriophage endolysin Ply511, Bacillus amyloliquefaciens
phage endolysin Morita2001, Bacillus anthracis prophage endoly-
sin PlyL, and Bacillus cereus phage endolysin Ply21 even increase
the muralytic activity (50, 83, 86–88). This pattern is also present
in endolysins with dual lytic domains, for which, in theory, both
should be equally active. Indeed, silent ECDs (almost devoid of
activity) have been observed in several multi-ECD endolysins
studied (streptococcal phage lambdaSa2 and B30 and staphylo-
coccal phage phi11 endolysins) (89–91). Interestingly, in all these
cases, the N-terminal ECD encodes the active domain with the
highest activity.
Signal peptides and transmembrane domains within phage
endolysins. The presence of N-terminal signal sequences in endo-
lysins suggests an alternative to the lambda paradigm and thus
provides a mode of action different from that of the great majority
of endolysins to access the PG at the end of the lytic phage cycle.
Signal sequences may enable transport of the endolysin through
the inner membrane to achieve the periplasm in a holin-indepen-
dent manner by making use of the host Secmachinery (24, 27, 77).
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Another alternative to the lambda paradigm is the SAR system,
in which the endolysin possesses a noncleavable N-terminal type
II signal anchor that remains part of the mature endolysin and
stays embedded in the inner cell membrane in an inactive form
(42, 92, 93). Consequently, these endolysins require pinholins to
cause a membrane depolarization to release the SAR anchor en-
abling the endolysin to get access to the cell wall (92, 94, 95).
A SAR endolysin system alone is thought to be the most prim-
itive phage-encoded lysis system, since, as a protein alone, it can
still produce lysis of the cell without the need of any additional
protein to achieve access to the PG. The pinholin-SAR endolysin
system may thus constitute an intermediate step in the evolution
of the canonical holin-endolysin two-component cell lysis system.
Because the acquisition of a holin results in a more abrupt or
saltatory time-determined lysis, this provides a selective advantage
for phage maturation by preventing slow host cell deterioration.
This system precedes the holin-endolysin system in which prema-
ture cell lysis is prevented by enabling the accumulation of large
amounts of endolysin in the cytoplasm before holins oligomerize
and allow contact between the endolysin and the PG.
From the created PGH database, 71 endolysins were predicted
to present a signal peptide. The search for the presence of SAR
domains revealed 103 endolysins presenting an N-terminal trans-
membrane domain, 38 of which have a high Gly/Ala content (40%
to 60%) and fewer than three basic residues (42, 96). These endo-
lysins were annotated as presenting a putative SAR sequence and
are listed in Fig. 4. From the 38 endolysins containing predicted
SAR sequences, roughly 85% are of the LYSO type, suggesting that
this type of PGH is the most primitive. While phage endolysins
presenting an N-terminal signal peptide are distributed randomly
among all phage families infecting different hosts, phage endoly-
sins with predicted SAR sequences are encoded only by phages
infecting G bacteria (mostly Enterobacteriaceae hosts), with the
exception of four lactococcal phage endolysins.
Unusual genetic endolysin organization. Usually, all phage
endolysins, exolysins, and bacterial autolysins are products of sin-
gle genes. However, within the studied genomes, nine phages were
found to present two ORFs encoding endolysins presenting three
uncommon features. First, the genomes from Gordonia phages
GRU1 and GTE5 and from Streptococcus phage 315.6 contain two
ORFs coding for an endolysin. However, they were considered a
single product since the concatenated gene products present ho-
mology with single proteins from other systems. It was recently
suggested that they were once encoded by a single gene or possibly
fused in other systems (97). Second, the phages Enterococcus
phiEf11, Microcystis Ma-LMM01, Streptococcus M102, Thermus
P23-77, and Synechococcus CBS2 and SPM2 encode two predicted
endolysins often found in adjacent genes and proximate to the
putative holin ORF. Since no homology was found with single
products, one possible scenario is that these phages can harbor
two distinct endolysins with different cleavage sites that act simul-
taneously. The presence of a double lytic system in Lactococcus
KSY1, containing two holins (ORF 53b and ORF 72) and two
endolysins (ORF 53a and ORF 73), can reinforce this hypothesis
(98). The third group reported here relates to endolysins formed
as a product of two adjacent genes containing group I introns, as
reported for the staphylococcal phage endolysins X2, G1, and 85
(99) or staphylokinase in phage phiNM3. Concerning these endo-
lysins, there is no report of these ORFs encoding a functional
protein besides their homology with a NUMOD4 motif and an
HNH endonuclease or staphylokinase in phage phiNM3. These
putative introns raise questions regarding their role in phage ge-
nome evolution. It has been suggested that introns can be involved
in the process of exonization of intronic sequences or exon shuf-
fling (100). In these cases, as introns are located between two dif-
ferent lytic domains, they probably enhance the chances of do-
main recombination in these regions, increasing the chances of
exon shuffling.
Cladogram phage-host-endolysin relationship. To compre-
hend the possible evolutionary position of phage endolysins, a
maximum likelihood tree was constructed. By analyzing the cla-
dogram (Fig. 5), we were able to perceive the great variety of en-
dolysin domain structures, generally with conserved ECDs and
little homology within the CBDs. Interestingly, there is no distinct
clade organization, which shows that the tree is not conceived by
just one factor, such as phage family, host, or ECD.
For tailed phages, the parameter that is apparently more im-
portant for the cladogram organization is the endolysins’ domain
architecture, which is visible on the highlighted clades—the more-
robust clades.
Regarding nontailed phage endolysins, Escherichia-like endo-
lysins from Tectiviridae contain an SLT catalytic domain and, as
expected, they are in the same evolutionary clade. However, it was
reported that, despite the amount of similar Tectiviridae genomes,
one of the major differences was observed when comparing their
lytic enzymes (101). Oppositely, Cystoviridae Pseudomonas-like
endolysins appear not to be conserved, as they are dispersed over
the tree.
Concluding remarks. The ubiquity and huge genetic diversity
found in phages are a result of both vertical and horizontal evolu-
tion. Through these processes, phages have acquired different lytic
systems employing PG-degrading enzymes to fight a diversified
and changeable bacterial cell wall. Therefore, endolysins can be
seen as an important result of phage evolution to permit rapid
adaptation to new environmental conditions. The fact that PG
degradation leads to bacterial death has intensified a particular
interest in the study of endolysins in an era in which the threat of
antibiotic and multiresistant bacteria is increasing and solutions
are scarce.
The work presented herein provides the first complete list of
all known endolysins encoded by dsNA completely sequenced
phage genomes as well their structure and predicted mecha-
nisms of action. Novel endolysins and endolysin domains are
here described, and further biological studies are needed to
understand their molecular and biological basis. Through an
increasing knowledge on protein design and with better molec-
ular biology tools available, it is expected that more engineered
endolysins can make the transition from the proof-of-principle
stage to industrial and medical use.
The annotation of ECDs within endolysins is an important
issue and thus far has been less than optimal. Simply calling all
endolysins lysozymes as a generic term for PGHs has created his-
torical misconception. Unfortunately, this older nomenclature
persists. We intend to resolve previous issues in nomenclature and
would like to encourage a universal annotation of phage endoly-
sins and even the creation of an endolysin database.
Only then can we begin to understand and appreciate the fas-
cinating meticulous evolutionary histories that individual phages
have taken to lyse host cells and facilitate the virus egress at the end
of its lytic cycle.
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